🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yilun Deng

Hunan Normal University

ORCID: 0000-0002-7209-7855

Also affiliated with Changsha Normal University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects”.

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-004871

N/A

0.385DataRank · unranked

12 citations

Álvaro Padrón, Yilun Deng, Yiji Liao, Clare J Murray, Carlos Ontiveros +9 more

Functional characterization of germline variants in the TMEM127 tumor suppressor reveals novel insights into its membrane topology and trafficking

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.08.031039

N/A

0DataRank · unranked

1 citations

Yilun Deng, Ziming Cheng, Xingyu Zhang, Sifan Tao, Afaf Saliba +5 more

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Cancer Medicine(2021)10.1002/cam4.3739

N/A

0DataRank · unranked

47 citations

Ryan M. Reyes, Erica Osta, Suresh Kari, Harshita B. Gupta, Álvaro Padrón +10 more

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002051

N/A

0DataRank · unranked

22 citations

Yilun Deng, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Karen Wheeler +11 more

Targeting Ovarian Cancer with IL-2 Cytokine/Antibody Complexes: A Summary and Recent Advances

PubMed(2021)10.33696/immunology.3.122

N/A

0DataRank · unranked

2 citations

Ryan M. Reyes, Chenghao Zhang, José R. Conejo-García, Tyler J. Curiel, Yilun Deng

234 Distinct efficacy and immunological responses to αPD-1, αPD-L1 and αPD-L2 immunotherapy in aged versus young hosts

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.234

N/A

0DataRank · unranked

0 citations

Harshita B. Gupta, Myrna Garcia, Aravind Kancharla, Ryan M. Reyes, Álvaro Padrón +2 more

Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice

Aging and Cancer(2022)10.1002/aac2.12045

N/A

0DataRank · unranked

29 citations

Yilun Deng, Clare Murray, Ryan M. Reyes, Álvaro Padrón, Haiyan Bai +5 more

Pharmacologic Tumor PDL1 Depletion with Cefepime or Ceftazidime Promotes DNA Damage and Sensitivity to DNA-Damaging Agents

International Journal of Molecular Sciences(2022)10.3390/ijms23095129

N/A

0DataRank · unranked

11 citations

Eva Galvan, Carlos Ontiveros, Yilun Deng, Haiyan Bai, Álvaro Padrón +6 more

501 Anti-PDL2 uses IL17-driven interferon-gamma to treat aged but not young cutaneous melanoma-bearing mice, and treats other tumors in an age- and TME-dependent manner

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0501

N/A

0DataRank · unranked

0 citations

Yilun Deng, Clare Murray, Carlos Ontiveros, Álvaro Padrón, Sladjana Skopelja‐Gardner +4 more

453 Pharmacologic tumor PDL1 depletion as a translational approach to inhibit tumor-intrinsic PDL1 signals and create novel treatment vulnerabilities

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0453

N/A

0DataRank · unranked

0 citations

Haiyan Bai, Anand Kornepati, Carlos Ontiveros, Yilun Deng, Álvaro Padrón +4 more

1428 Melanocyte-intrinsic PDL1 promotes tumorigenesis and progression in a novel autochthonous melanoma model

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.1428

N/A

0DataRank · unranked

0 citations

Yilun Deng, Anand Kornepati, Clare Murray, Mary Jo Turk, Harshita B. Gupta +3 more

Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors

Molecular Cancer(2024)10.1186/s12943-024-02147-z

N/A

0DataRank · unranked

11 citations

Anand Kornepati, Carlos Ontiveros, Yiji Liao, Bárbara de la Peña Avalos, Cody M. Rogers +25 more

Functional Characterization of TMEM127 Variants Reveals Novel Insights into Its Membrane Topology and Trafficking

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgaa396

N/A

0DataRank · unranked

17 citations

Yilun Deng, Ziming Cheng, Xingyu Zhang, Sifan Tao, Afaf Saliba +7 more

Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling

Nature Communications(2025)10.1038/s41467-025-65025-2

N/A

0DataRank · unranked

2 citations

Myrna Garcia, Clare Murray, Yilun Deng, Haiyan Bai, Christopher Tanner +17 more